New treatment tested for painful genital eczema
NCT ID NCT07444801
Summary
This study is observing how well an existing eczema medication called tralokinumab works for people whose moderate-to-severe eczema affects their genital area. Over 52 weeks, researchers will track 30 adult patients who are already starting this treatment as part of their regular care. They will measure changes in symptoms, skin appearance, and quality of life using specific questionnaires and imaging tools.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS (MODERATE-TO-SEVERE) INVOLVING THE GENITAL REGION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CCIM, Institut für Entzündungsmedizin UKSH Lübeck
RECRUITINGLübeck, Schleswig-Holstein, 23538, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Department of Dermatology of the University Hospital Augsburg
RECRUITINGAugsburg, München, 86156, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.